Clinical Trial Results:
A multinational, randomized, double-blind placebo controlled study of AVE8062 (25 mg/m²) administered every 3 weeks in patients with advanced-stage soft tissue sarcoma, treated with cisplatin (75 mg/m²) after failure of anthracycline and ifosfamide chemotherapies.
Summary
|
|
EudraCT number |
2007-003592-39 |
Trial protocol |
FR BE ES GB HU IT |
Global completion date |
17 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 May 2016
|
First version publication date |
10 May 2016
|
Other versions |
|
Summary report(s) |
EFC10145 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.